Lior Rokach

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Randomized Controlled Trial

Chronic Lymphocytic Leukemia

Prognostic Factors

Top Venues

Entropy (Basel, Switzerland)

Molecular systems biology

This page only lists publications with an associated author ORCID identifier.

Publications

Tamar Tadmor, Guy Melamed, Hillel Alapi, Sivan Gazit, Tal Patalon, Lior Rokach
Supplement of Vitamin D for early-stage Chronic Lymphocytic Leukemia Patients is Associated with a Longer Time to first Treatment. Blood advances (2024)
Tamar Tadmor, Guy Melamed, Hilel Alapi, Sivan Gazit, Tal Patalon, Lior Rokach
Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment. Blood advances 8 (14) (2024)
Chanan M Argov, Ariel Shneyour, Juman Jubran, Eric Sabag, Avigdor Mansbach, Yair Sepunaru, Emmi Filtzer, Gil Gruber, Miri Volozhinsky, Yuval Yogev, Ohad Birk, Vered Chalifa-Caspi, Lior Rokach, Esti Yeger-Lotem
Tissue-aware interpretation of genetic variants advances the etiology of rare diseases. Molecular systems biology (2024)
Tamar Tadmor, Guy Melamed, Hilel Alapi, Sivan Gazit, Tal Patalon, Lior Rokach
Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment. Blood advances 8 (14) (2024)
Tamar Tadmor, Hillel Alapi, Lior Rokach
Effectiveness of nirmatrelvir plus ritonavir treatment for patients with CLL during the Omicron Surge. Blood (2023)
Seffi Cohen, Niv Goldshlager, Bracha Shapira, Lior Rokach
TTANAD: Test-Time Augmentation for Network Anomaly Detection. Entropy (Basel, Switzerland) 25 (5) (2023)
Ben Nassi, Jacob Shams, Lior Rokach, Yuval Elovici
Virtual Breathalyzer: Towards the Detection of Intoxication Using Motion Sensors of Commercial Wearable Devices. Sensors (Basel, Switzerland) 22 (9) (2022)